Skip to content
Contact Us | Sharepoint Login
Join us in the advancement
of cardiac safety research, knowledge, and excellence
join button Join Us button watch the csrc video JOIN Watch The CSRC Story
Search
 
return to home Cardiac Safety Research Consortium

Cardiac Safety Research Consortium

A Consortium involved in supporting research

  • Home
  • About Us
    • Mission and Program Objectives
    • Scientific Rationale
    • Organization
    • Committees
    • Memorandum of Understanding
    • Members
    • Collaborators
    • How to Join
    • News
    • Report Card
  • Projects
    • CiPA Update
  • Publications
    • White Papers
    • CSRC Five Year Report
    • CSRC 10 Year Anniversary Book
    • CSRC 10 Year Vignette Book
  • Think Tanks
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
  • ECG Database
  • Non-CV Clinical Trials CRF
  • Governance
    • Governance Charter
    • Membership Charter
    • CSRC White Paper Policy

Christian J, et al. Cardiac Imaging for the Evaluation of Drug Induced Cardiotoxicity. Am Heart J. 2012; 164(6) : 846-855

Posted on August 13, 2012July 25, 2016 by Cardiac Safety

View Paper Here

Related

This entry was posted in Publications. Bookmark the permalink.

Post navigation

← Methodologies to characterize the QT/corrected QT interval in the presence of drug-induced heart rate changes or other autonomic effects
Pediatric cardiovascular safety: Challenges in drug and device development and clinical application →

UPCOMING EVENTS

SAVE THE DATE

April 4, 2019:
NOAC Use in the Pediatric Population: Defining the Path Forward

April 5, 2019

POSTPONED: Driving Efficiencies in Clinical Trials through the use of Cardiac Biomarkers

June 10, 2019:
Defining the Clinical and Regulatory Landscape for Cardiogenic Shock: II

See information on upcoming events.

Related

NEWS & UPDATES

The October 2018 CiPA Update is Now Available

Read the update to catch up on the latest information.

CSRC and ACCP Sign Collaborative Memorandum of Understading

Through the partnership, CSRC and ACCP will develop, plan, and conduct various educational events and programs and produce research and policy statements/position papers regarding clinical pharmacology and cardiac and vascular safety of medical products.

Follow us on LinkedIn

Follow CSRC on LinkedIn to stay current on cardiac safety topics.

Related

CURRENT PROJECTS

  • CSRC Prevention of Sudden Cardiac Death in the Young: National Cardiac Screening Warehouse Pilot Study
  • *If you would like to get involved, please contact us at cardiacsafety@dm.duke.edu.

Related

Related

Submit your Form for a new QT Project

Social

  • Twitter
Log in
The mission of the Cardiac Safety Research Consortium is to advance regulatory science specifically related to pre-competitive cardiac safety issues through the collaborative means of a public-private partnership across interested stakeholders. The CSRC stands fully ready to encourage, contribute to, embrace and support elements of clinical science such as good scientific design, data analysis, interpretation and dissemination to the public domain within the construct of the resources and committee structure of the public-private partnership forum.

The CSRC does not endorse specific commercial technologies, entities, products, or services. Any communications to the contrary, written or otherwise, are inaccurate.
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.